Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,131.60
(
-0.27%
)
Dow Jones
50,644.28
(
0.36%
)
Brent Oil
94.00
(
1.68%
)
Bitcoin
74,392.69
(
-0.66%
)
News Focus
News Focus
Post# of 257648
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123029
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: oc631 post# 102114

Sunday, 08/22/2010 11:04:01 AM

Sunday, August 22, 2010 11:04:01 AM

Post# of 257648

VRUS—I was just posing the question…

It sounded like you were doing a bit more than just posing :- )

In general, your posts strike me as somewhat gullible with respect to VRUS’ talking points. VRUS is a fine company that has a nice portfolio of HCV drugs, but they do not have anything radically different from the pyrimidine and purine nukes of other HCV companies.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today